Condensed Consolidated Statements Of Cash Flows - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023
Cash flows from operating activities:
Net income	$ 35,516	$ 17,495
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	132,728	120,013
Amortization of debt discount	161
Amortization of debt issuance costs	1,611	1,840
Share-based compensation	5,524	4,765
Deferred income taxes	13,167	6,940
(Gain) loss on disposition of assets, net	50	(367)
Losses related to convertible senior notes	20,922
Unrealized foreign currency loss	(1,213)	11,587
Change in fair value of contingent consideration		31,319
Changes in operating assets and liabilities:
Accounts receivable, net	12,741	(96,027)
Other current assets	(13,778)	(16,774)
Income tax payable	(509)	(2,518)
Accounts payable and accrued liabilities	(73,169)	31,142
Deferred recertification and dry dock costs, net	(29,239)	(59,216)
Other, net	3,539	7,521
Net cash provided by operating activities	108,051	57,720
Cash flows from investing activities:
Capital expenditures	(10,780)	(16,165)
Proceeds from sale of assets	100	365
Proceeds from insurance recoveries	363
Net cash used in investing activities	(10,317)	(15,800)
Cash flows from financing activities:
Payments related to convertible senior notes	(60,720)	(30,415)
Repayment of MARAD Debt	(8,749)	(8,333)
Proceeds from settlement of capped calls	4,381
Debt issuance costs	(1,453)	(236)
Repurchases of common stock	(10,189)	(11,988)
Payments related to tax withholding for share-based compensation	(4,003)	(1,385)
Proceeds from issuance of ESPP shares	1,859	982
Payment of earn-out consideration	(26,700)
Net cash used in financing activities	(105,574)	(51,375)
Effect of exchange rate changes on cash and cash equivalents	(231)	(11,286)
Net decrease in cash and cash equivalents	(8,071)	(20,741)
Cash and cash equivalents:
Balance, beginning of year	332,191	189,111
Balance, end of period	$ 324,120	$ 168,370